Anesthesiology & Pain Medicine >> Research >> Centers >> C-PRIME Grants & Awards

UW Pain: C-PRIME
Grants & Awards


  • 2011—2016National Institute of Nursing Research, R01NR012450, “Palliative care symptom management in rural communities”, B. Theodore, Co-Investigator [A. Doorenbos, Principal Investigator], Total Costs: $2,723,977
  • 2012—2015Agency for Healthcare Research and Quality, 1R01HS021233-01A1, “Modeling and Analysis of Clinical Care for HIT Improvement”, B. Theodore, Co-Investigator, [K. Butler, Principal Investigator], Total Cost: $1,361,560
  • 2012—2016Health Resources and Services Administration, H2ARH24951-01-00, “Enhancing Rural Primary Care Access to Mental Health and Opioid Management Consultations in Washington via Telehealth”, B. Theodore, Co-Investigator, [R. Veith, Principal Investigator], Total Cost: $850,000
  • 2012—2017National Institute of Drug Abuse grant, 1R01DA032776, “Clinical and Genetic Characteristics of Opioid Addiction in Chronic Pain”, D. Turk, Co-investigator, [C. O’Brien, Principal Investigator, transferred to M. Cheatle], total direct costs: $2,026,511
  • 2013—2014Military Order of the Purple Heart Service Foundation. “Developing Mobile Solutions for Assessment and Treatment of Soldiers and Veterans suffering from mild Traumatic Brain Injury, Post Traumatic Stress Disorder, and Chronic Pain”. B. Theodore, Principal Investigator, Total Cost: $100,000.
  • 2013—2014Synthes Spinal Surgery Outcomes Research Endowment, UW Department of Department of Orthopaedics and Sports Medicine. “Implementation of ActionTracker at Sports Medicine Center at Husky Stadium”, B. Theodore, Co-Investigator [D. Tauben, J. Chapman, Co-Principal Investigators], Total Cost: $200,000.
  • 2014—2015REMS Program Companies (REMS PC), “COPE-REMS Training Program, Phase II”, B. Theodore, Co-Investigator [M. Sullivan, Principal Investigator], Total Costs: $789,900
  • 2014—2016American Pain Society Grant, “Expanding Treatment of Chronic Pain in Older Adults: Community-based Exercise+CBT”, Co-Investigator [K. Patel, Principal Investigator], total direct costs: $35,000
  • 2014—2016Patient Centered Outcomes Research Institute (PCORI). “Extending PROMIS Pain Item Banks: Pain Self-efficacy and Pain Catastrophizing”, D. Turk, Co-Investigator [D. Amtmann, Principal Investigator], total direct costs: $500,000
  • 2014—2016Advanced Medical Technology Association. “Identifying Treatment Responders and Treatment Effect Moderators in Randomized Clinical Trials of Hyaluronic Acid for Osteoarthritis Knee Pain”, D. Turk, Co-Principal Investigator [R.H. Dworkin, Principal Investigator], Total costs: $491,000
  • 2014—2017US Food & Drug Administration, “Analysis of FDA Clinical Trial Data to Improve the Assay Sensitivity and Informativeness of Analgesic Clinical Trials”, Contract HHSF223201400191C, D. Turk, Co-Investigator [R.H. Dworkin, Principal Investigator], total costs: $151,799
  • 2015—2017Congressionally Directed Medical Research Program “Enhancing the Success of Functional Restoration using Integrative Pain Therapies: a Comparative Effectiveness Analysis in Active Duty Service Members with Chronic Pain”, B. Theodore, A. Doorenbos, D. Flynn, Co-Principal Investigators, Total Costs: $999,981
  • 2010—2013 National Institutes on Drug Abuse, 1R01DA026887-01A1,
    "Web-based CBT for Opioid-treated Chronic Pain Patients with Aberrant Behavior", Co-investigator [Marsch LA, Rosenblum AB, Co-PIs], total direct cost $1,762,633
  • 2010—2013 National Institutes on Drug Abuse, 1R01DA026887-01A1,
    "Web-based CBT for Opioid-treated Chronic Pain Patients with Aberrant Behavior", Co-investigator [Marsch LA, Rosenblum AB, Co-PIs], total direct cost $1,762,633
  • 2011—2016 National Institute of Drug Abuse, R01DA032776-01, "Clinical and Genetic Characteristics of Opioid Addiction in Chronic Pain", Co-investigator [O'Brien CP, PI], total direct costs: $2,333,475 [UW subcontract $466,695]
  • 2011—2016 Food and Drug Administration, 1U01FD004187-01, "Analgesic Clinical Trials Innovations, Opportunities and Networks (ACTION)", [Dworkin RH, PI], total direct costs: $3,846,490
  • 2011—2016 National Institute of Arthritis and Musculoskeletal and Skin Disease, 1R01AR059102-01A1, "Combined Behavioral and Analgesic Trial for Fibromyalgia (COMBAT-FM)", total direct costs: $3,846,490
  • 2010—2012 United States Army Medical Research Acquisition Activity (USAMRAA), W81XWH-11-2-0055, "Chronic Pain Impact Network (CPAIN)", total direct costs: $210,135